Jacqueline Karmel

Jacqueline Karmel is an accomplished professional in the field of oncology and clinical research, currently serving as Chair of the imCORE Executive Office and as Principal International Scientific Director for Cancer Immunotherapy at Roche since January 2016. With extensive experience that includes roles such as Managing Director at Precision Clinical Ltd. and various strategic positions at Genentech, Karmel has demonstrated expertise in regional strategy and clinical operations across Europe and beyond. Previous positions include Director of European Clinical Operations at Millennium Pharmaceuticals, Clinical Program Manager at Eisai Pharmaceuticals India, and Associate Director of International Clinical Research at The Liposome Company. Karmel's academic background includes studies at the University of Southampton and the University of Surrey.